Skip to main content

Table 1 Baseline clinical characteristics of 315 ATC patients with DM

From: The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis

 

No. patients (%)

Gender

 

 Female

160 (50.79%)

 Male

155 (49.21%)

Age at diagnosis

 

 Median[min-max]

70.00[23.00,90.00]

Race

 

 Non-Hispanic White

182 (57.78%)

 Hispanic White

53 (16.83%)

 Black

20 (6.35%)

 Others

60 (19.05%)

T Stage 1

 

 T1/2

17 (5.40%)

 T3

66 (20.95%)

 T4

232 (73.65%)

N Stage

 

 N0

79 (25.08%)

 N1

236 (74.92%)

Tumor Diameter

 

 ≤ 6 cm

123 (39.05%)

 > 6 cm

192 (60.95%)

Tumor Extension

 

 Limited to Thyroid

65(20.63%)

 Extrathyroidal Extension

250 (79.37%)

Distant Lymph Node Metastasis

 

 No

215(68.25%)

 Yes

100(31.75%)

Bone Metastasis

 

 No

246(78.10%)

 Yes

69(21.90%)

Brain Metastasis

 

 No

296(93.97%)

 Yes

19(6.03%)

Liver Metastasis

 

 No

287(91.11%)

 Yes

28(8.89%)

Lung Metastasis

 

 No

49(15.56%)

 Yes

266(84.44%)

Multiple Organ Metastases

 

 No

244(77.46%)

 Yes

71(22.54%)

Marital status

 

 Single (never married)

40(12.70%)

 Married

189(60.00%)

 Divorced/Separated/Widowed

83(26.35%)

 Unknown

3(0.95%)

Surgery to Primary Site

 

 No

202 (64.13%)

 Non-thyroidectomy

35 (11.11%)

 Thyroidectomy

78 (24.76%)

Radiotherapy

 

 No

132 (41.90%)

 Yes

183 (58.10%)

Chemotherapy

 

 No

166 (52.70%)

 Yes

149 (47.30%)

  1. 1 Refined to AJCC 8th edition according to tumor extension and tumor diameter